• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals


1.9200 USD 0.0500 2.67%

As of 17:20:00 ET on 04/16/2014.

Snapshot for EntreMed Inc (ENMD)

Open: 1.8700 Day's Range: 1.8700 - 1.9300 Volume: 5,634
Previous Close: 1.8700 52wk Range: 1.4500 - 2.3800 1-Yr Rtn: -6.34%

Stock Chart for ENMD

No chart data available.
  • ENMD:US 1.9200
  • 1D
  • 1M
  • 1Y
Interactive ENMD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ENMD

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.2200
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 51.92
Shares Outstanding (M) 27.04
30 Day Average Volume 24,770
Price/Book (mrq) 3.3038
Price/Sale (ttm) 64.5538
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/20/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ENMD

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ENMD

EntreMed, Inc. researches and develops biopharmaceutical products that focus on the role of blood and blood vessels in health and disease. The Company's products present antiangiogenic solutions to cancer, cardiovascular disease, and macular degeneration. Therapeutics currently being researched include Endostatin and Angiostatin.

He Wei-WuChairmanDwight L Bush SrVice Chairman
Ken K RenChief Executive OfficerCynthia Wong HuVP/COO/Secy/General Counsel
More Company Profile & Key Executives for ENMD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil